NEWS
>
Press Releases
December 19, 2011 - IAVI and Partners Initiate AIDS Vaccine Trial in Africa
View Release
April 18, 2011 - US Department of Defense Awards Grant to Ichor Medical Systems to Evaluate Skin Electroporation Device for Delivery of Multi-agent DNA Vaccines
View Release
January 5, 2011 - Profectus Biosciences Announces Initiation of Clinical Trial of IL-12 Enhanced Therapeutic HIV DNA Vaccine Delivered Using Electroporation
View Release
September 23, 2010 - Vaxonco's EP1300 Epitope-Based DNA Vaccine for Malaria Delivered by Ichor's TriGrid™ Electroporation Enters Phase I Trial
View Release
July 26, 2010 - Ichor Medical Systems Awarded Contract to Further Development of Vaccine for Biodefense Pathogen
View Release
June 15, 2010 - SCIB1 Phase I Trial Commences - First Patient Treated
View Release
May 5, 2010 - Clinical Trial Approval for SCIB1 Melanoma Vaccine Study
View Release
March 2, 2010 - Ichor Medical Systems and Profectus Biosciences Enter into an Agreement for Use of TriGrid Electroporation Device to Develop Multiple DNA Vaccines
View Release
February 2, 2010 - Clinical Trial Application for SCIB1 melanoma vaccine
View Release
November 30, 2009 - Phase I Study of Preventive HIV Vaccine Shows Improved Immune Responses when the Vaccine is Delivered by Electrical Impulses
View Release
August 5, 2009 - Ichor Medical Systems Awarded $3.3 Million NIH Grant to Develop Alzheimer's Disease Vaccine
View Release
July 16, 2009 - Scancell Licenses TriGrid™ Electroporation Device from Ichor Medical Systems
View Release
October 17, 2008 - Preliminary Phase I Safety Data for Preventive HIV Vaccine Delivered by Ichor’s TriGrid to be Presented at AIDS Conference
View Release
March 10, 2008 - Pharmexa and Ichor Medical Systems Enter into an Agreement to Co-develop Multiple DNA Vaccines Delivered by Electroporation
View Release
March 4, 2008 - Ichor Melanoma Vaccine Clinical Trial Moves to the Highest Dose Level
View Release
October 1, 2007 - Ichor Medical Systems' TriGrid Selected as Delivery Platform in Collaboration to Test Preventative HIV Vaccine
View Release
August 6, 2007 - Navy Partners with Ichor Medical Systems to Develop a Vaccine for Anthrax and Plague
View Release
June 18, 2007 - Ichor Medical Systems Selects Gable PR
View Release
May 14, 2007 - FDA Approves Phase I Clinical Trial Using Ichor's TriGrid System and DNA Vaccine for Melanoma Developed at Sloan-Kettering
View Release
March 26, 2007 - Interferon Beta DNA Treatment Delivered with Ichor Technology Reduces Atherosclerosis Progression in Mice
View Release
March 5, 2007 - United States Department of Defense Selects Ichor Medical Systems to Develop Biodefense Vaccine
View Release
December 18, 2006 - Pharmexa-Epimmune and Ichor Medical Systems Enter into a Collaborative Agreement
View Release
August 24, 2005 - Ichor Medical Systems Awarded Key Electroporation Patent
View Release
June 28, 2005 - Ichor Medical Systems Settlement Agreement Approved
View Release
September 4, 2003 - Ichor Medical Systems, Inc. Secures Rights to Interleukin-12 from The Wistar Institute
View Release
June 12, 2003 - Ichor Medical Systems Prevails in Equitable Assignment Judgment
View Release
May 14, 2003 - Ichor Medical Systems Awarded $13.5 Million in "Pivotal" Intellectual Property Verdict
View Release